DD283402A5 - Verfahren zur herstellung von 2-substituierten adenosinderivaten - Google Patents

Verfahren zur herstellung von 2-substituierten adenosinderivaten Download PDF

Info

Publication number
DD283402A5
DD283402A5 DD89324859A DD32485989A DD283402A5 DD 283402 A5 DD283402 A5 DD 283402A5 DD 89324859 A DD89324859 A DD 89324859A DD 32485989 A DD32485989 A DD 32485989A DD 283402 A5 DD283402 A5 DD 283402A5
Authority
DD
German Democratic Republic
Prior art keywords
group
lower alkyl
hydrogen
groups
pharmaceutically acceptable
Prior art date
Application number
DD89324859A
Other languages
German (de)
English (en)
Inventor
Alan J Hutchison
John E Francis
Original Assignee
����`��@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k�� filed Critical ����`��@���k��
Publication of DD283402A5 publication Critical patent/DD283402A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DD89324859A 1988-01-07 1989-01-05 Verfahren zur herstellung von 2-substituierten adenosinderivaten DD283402A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14205588A 1988-01-07 1988-01-07
US07/193,968 US5034381A (en) 1988-01-07 1988-05-13 2-(substituted amino) adenosines as antihypertensives

Publications (1)

Publication Number Publication Date
DD283402A5 true DD283402A5 (de) 1990-10-10

Family

ID=26839719

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89324859A DD283402A5 (de) 1988-01-07 1989-01-05 Verfahren zur herstellung von 2-substituierten adenosinderivaten

Country Status (17)

Country Link
US (1) US5034381A (fi)
EP (1) EP0323807A3 (fi)
JP (1) JPH01265100A (fi)
KR (1) KR890011903A (fi)
AU (1) AU618055B2 (fi)
CA (1) CA1325209C (fi)
DD (1) DD283402A5 (fi)
DK (1) DK5089A (fi)
FI (1) FI90430C (fi)
HU (1) HU202550B (fi)
IL (1) IL88877A0 (fi)
MX (1) MX14446A (fi)
NO (1) NO169843C (fi)
NZ (1) NZ227542A (fi)
PH (1) PH26672A (fi)
PT (1) PT89392B (fi)
ZA (1) ZA8984B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977144A (en) * 1988-08-02 1990-12-11 Ciba-Geigy Corporation Imidazo[4,5-b]pyridine derivatives as cardiovascular agents
AU3820989A (en) * 1988-08-02 1990-02-08 Ciba-Geigy Ag 7-amino-3-beta-d-ribofuranosyl-3h-imidazo(4,5-b) pyridin-5-amine derivatives
US5189027A (en) 1990-11-30 1993-02-23 Yamasa Shoyu Kabushiki Kaisha 2-substituted adenosine derivatives and pharmaceutical compositions for circulatory diseases
US5206222A (en) * 1991-05-22 1993-04-27 Vanderbilt University Methods for the reduction of myocardial reperfusion injury
IT1254915B (it) * 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista
IL107101A0 (en) * 1992-09-30 1993-12-28 Merrell Dow Pharma 2-substituted adenosines with a-2 receptor affinity
US5426101A (en) * 1992-09-30 1995-06-20 Merrell Dow Pharmaceuticals Inc. 2-substituted adenosines with A-2 receptor affinity
WO1994023723A1 (en) * 1993-04-15 1994-10-27 New York University Adenosine receptor agonists for the promotion of wound healing
US5817641A (en) * 1994-07-21 1998-10-06 Thomas Jefferson University Treatment of enterotoxigenic diarrhea with 2-substituted adenosine derivatives
AU740770B2 (en) 1997-06-18 2001-11-15 Aderis Pharmaceuticals, Inc. Compositions and methods for preventing restenosis following revascularization procedures
US5972903A (en) * 1997-10-07 1999-10-26 Regents Of The University Of California Corporation Method for promoting angiogenesis using heparin and adenosine
WO1999017784A1 (en) 1997-10-07 1999-04-15 Regents Of The University Of California Corporation Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine
AU751470B2 (en) * 1998-07-09 2002-08-15 Sequella, Inc. Novel antibacterial compounds
AU4343500A (en) 1999-04-16 2000-11-02 Schering Corporation Use of azetidinone compounds
TWI245047B (en) * 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
US20050033044A1 (en) 2003-05-19 2005-02-10 Bristol-Myers Squibb Pharma Company Methods for preparing 2-alkynyladenosine derivatives
MX2007009783A (es) 2005-02-17 2007-08-22 Wyeth Corp Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilfusionados.
US20090136460A1 (en) * 2007-07-10 2009-05-28 Vanderbilt University Use of adenosine receptor ligands to promote cell adhesion in cell-based therapies
AU2014340114B2 (en) * 2013-10-23 2018-10-18 Academia Sinica Compounds for use in prevention and treatment of neurodegenerative diseases and pain

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670265A1 (de) * 1967-08-25 1971-01-28 Boehringer Mannheim Gmbh 2-Amino-Adenosinderivate und Verfahren zu deren Herstellung
NL7203984A (fi) * 1971-04-10 1972-10-12
US3917583A (en) * 1972-08-04 1975-11-04 Icn Pharmaceuticals 2-Substituted cyclic AMP derivatives
AR205247A1 (es) * 1973-02-07 1976-04-21 Icn Pharmaceuticals Procedimiento para preparar derivados de amp 2-substituidos
JPS5630355B2 (fi) * 1974-01-21 1981-07-14
AU5118979A (en) * 1978-10-16 1980-04-24 Takeda Chemical Industries Ltd. 2,6-diaminoebularines
JPS55139399A (en) * 1979-04-12 1980-10-31 Asahi Chem Ind Co Ltd Novel adenosine derivative substituted in the 2-position
JPS56152437U (fi) * 1980-04-14 1981-11-14
US4501735A (en) * 1983-12-05 1985-02-26 Warner-Lambert Company N6-(1- and 2-benzocycloalkyl) adenosines
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
DE3587717T2 (de) * 1984-04-18 1994-04-28 Whitby Research Inc N-6-thienyl-substituierte Adenosinderivate als herzgefässerweiternde Mittel.
US4594350A (en) * 1984-07-30 1986-06-10 Reagents Of University Of Minnesota (3-ethoxypropionate) esters of cyclaradine
US4683223A (en) * 1985-09-09 1987-07-28 Warner-Lambert Company N6 -Benzopyrano-and benzothiopyrano adenosines and methods of use
US4593019A (en) * 1984-10-26 1986-06-03 Warner-Lambert Company N6 -tricyclic adenosines
US4791103A (en) * 1985-02-08 1988-12-13 Warner-Lambert Company 2,N6 -disubstituted adenosines, derivatives and methods of use
US4600707A (en) * 1985-01-25 1986-07-15 Warner-Lambert Company Benzothien-3-yl adenosine; benzothien-3-yl adenosine, S-oxide; and benzothien-3-yl, S,S-dioxide adenosine compounds
US4755594A (en) * 1986-01-31 1988-07-05 Warner-Lambert Company N6 -substituted adenosines
US4843066A (en) * 1986-11-27 1989-06-27 Nippon Zoki Pharmaceutical Co., Ltd. Novel adenosine derivatives and pharmaceutical composition containing them as an active ingredient
EP0277917A3 (en) * 1987-02-04 1990-03-28 Ciba-Geigy Ag Certain adenosine 5'-carboxamide derivatives

Also Published As

Publication number Publication date
CA1325209C (en) 1993-12-14
FI90430B (fi) 1993-10-29
NO169843C (no) 1992-08-12
US5034381A (en) 1991-07-23
NO885821D0 (no) 1988-12-30
JPH01265100A (ja) 1989-10-23
MX14446A (es) 1994-01-31
HU202550B (en) 1991-03-28
AU2776789A (en) 1989-07-13
FI890028A0 (fi) 1989-01-04
EP0323807A3 (en) 1990-06-20
PT89392B (pt) 1993-09-30
NZ227542A (en) 1992-03-26
IL88877A0 (en) 1989-08-15
FI890028A (fi) 1989-07-08
ZA8984B (en) 1989-08-30
PT89392A (pt) 1990-02-08
DK5089D0 (da) 1989-01-06
NO885821L (no) 1989-07-10
AU618055B2 (en) 1991-12-12
HUT48904A (en) 1989-07-28
FI90430C (fi) 1994-02-10
EP0323807A2 (en) 1989-07-12
PH26672A (en) 1992-09-15
NO169843B (no) 1992-05-04
DK5089A (da) 1989-07-08
KR890011903A (ko) 1989-08-23

Similar Documents

Publication Publication Date Title
DD283402A5 (de) Verfahren zur herstellung von 2-substituierten adenosinderivaten
DE69532195T2 (de) Benzamidverbindung und ihre medizinische verwendung
DE2915037C3 (de) Neue N-substituierte Moranolinderivate
AT363096B (de) Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen
DD273833A5 (de) N 9 - cyclopentylsubstituierte adeninderivate
CH660484A5 (de) In 1-stellung durch einen heterocyclischen rest substituierte 4-((2,5-pyrrolidindion-1-yl)alkyl)piperazin-verbindungen.
DD284679A5 (de) Verfahren zur herstellung von adenosin 5'-carboamidderivate
CH648553A5 (de) Neue 3,4-dihydro-5h-2,3-benzodiazepin-derivate und verfahren zur herstellung derselben.
DD299424A5 (de) Phenolderivate zur foerderung des menschlichen nervenwachstumsfaktors
DE2940833A1 (de) 2-methyl-dihydropyridin-verbindung, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel
EP0033156B1 (de) 1-Phenyl-2-cyclohexen-1-alkylamin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DD233847A5 (de) Verfahren zur herstellung von methylendiphosphon-derivaten mit antireuhmatischen eigenschaften
DE2461802A1 (de) Pyrazinderivate
DD207712A5 (de) Verfahren zur herstellung von diestern
DE3813531A1 (de) Neue 2-aminoalkyl-4-benzyl-1-(2h)-phthalazinon-derivate
DD284025A5 (de) Verfahren zur herstellung von imidazo(4,5-b)pyridin-derivaten
DD143613A5 (de) Verfahren zur herstellung von 4-amino-2-piperidino-chinazolin-derivaten
EP0110869A1 (de) Thienylessigsäureamidderivate und pharmazeutisch verträgliche Säureadditionssalze hiervon sowie Verfahren zu deren Herstellung
EP0256400A2 (de) Pyrimidinderivate, ihre Herstellung und Medikamente die diese Derivate enthalten
US5102896A (en) 1-acyl-2-pyrrolidinones as enhancers of learning and memory
DD213921A5 (de) Verfahren zur herstellung von substituierten nicotinamid 1-oxyd n- und seinen salzen
JPH037280A (ja) 新規ベンゾチオピラニルアミン
DE60311284T2 (de) 4-(3,5-dicyanophenoxy)pyrazol-derivate zur verwendung als reverse transkriptase modulatoren zur behandlung von u.a. hiv
DE2354931C2 (de) trans-2-Phenylbicyclooctan-Verbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DD298786A5 (de) Thiophene